Sleep Medicine
- Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
The authors review measures for preventing harm before benzodiazepines are prescribed, decreasing harm within 4 weeks after they are prescribed, and limiting harmful effects of long-term prescribing.
- ‘Guidelines to Practice’ series: Asthma in adults
A clinically useful summary, highlighting the practical and newer conceptual aspects of the guidelines.
- Outpatient management of asthma in adults: A snapshot of the 2020 GINA report
A review of the guidelines, with a focus on what’s new and clinically important.
- Quetiapine for primary insomnia: Consider the risks
Its cardiometabolic effects and potential for abuse warrant caution in off-label use.
- Is regular oxygen supplementation safe for obese postoperative patients?
Caution for some, but no evidence to support withholding it altogether.
- Beyond depression: Other uses for tricyclic antidepressants
The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.
- A link between A-fib and sleep apnea is no surprise, but why?
The two conditions commonly coexist, and treating the sleep apnea results in better rhythm-directed outcomes in the A-fib.
- Should I evaluate my patient with atrial fibrillation for sleep apnea?
Yes. The prevalence of sleep apnea is high in patients with atrial fibrillation, and vice versa.
- SEEDS for success: Lifestyle management in migraine
Lifestyle counseling can be based on the mnemonic SEEDS: sleep, exercise, eat, diary, and stress.
- What are the risks to inpatients during hospital construction or renovation?
Risks include mold infection, Legionnaires disease, sleep deprivation, exacerbation of lung disease, and physical injury.